Tuesday, November 25, 2008 4:53:55 PM
Repros Therapeutics Inc. - Common Stock
Settlement Date Short Interest Percent Change Average Daily Share Volume Days to Cover
11/14/2008 1,039,066 (1.55) 37,148 27.97
10/31/2008 1,055,407 (2.38) 35,544 29.69
10/15/2008 1,081,177 (10.86) 48,327 22.37
09/30/2008 1,212,861 (4.52) 98,358 12.33
09/15/2008 1,270,224 46.99 121,621 10.44
08/29/2008 864,144 61.84 70,305 12.29
08/15/2008 533,942 18.72 56,575 9.44
07/31/2008 449,758 35.49 73,583 6.11
07/15/2008 331,957 (0.23) 70,781 4.69
06/30/2008 332,729 (47.94) 50,158 6.63
06/13/2008 639,126 (24.99) 137,404 4.65
05/30/2008 852,103 (10.73) 62,820 13.56
05/15/2008 954,511 (6.56) 42,288 22.57
04/30/2008 1,021,502 3.04 54,807 18.64
04/15/2008 991,404 1.25 71,296 13.91
03/31/2008 979,155 (22.12) 113,826 8.60
03/14/2008 1,257,186 8.24 115,126 10.92
02/29/2008 1,161,472 0.86 59,932 19.38
02/15/2008 1,151,580 (9.95) 55,279 20.83
01/31/2008 1,278,783 (7.91) 77,639 16.47
01/15/2008 1,388,551 17.07 61,643 22.53
12/31/2007 1,186,120 35.63 128,710 9.22
12/14/2007 874,526 57.68 273,273 3.20
11/30/2007 554,631 39.90 111,740 4.96
http://www.nasdaqtrader.com/trader.aspx?id=ShortInterest
Recent RPRX News
- Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024 • GlobeNewswire Inc. • 07/19/2024 12:15:00 PM
- Royalty Pharma Declares Third Quarter 2024 Dividend • GlobeNewswire Inc. • 07/17/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:03:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:58:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 09:06:32 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/04/2024 09:12:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:57:02 PM
- Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 08:15:00 PM
- Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes • GlobeNewswire Inc. • 06/03/2024 09:15:27 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 06/03/2024 08:59:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/03/2024 01:13:40 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 06/03/2024 12:39:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 09:25:01 PM
- Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million • GlobeNewswire Inc. • 05/28/2024 11:10:00 AM
- Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline • GlobeNewswire Inc. • 05/22/2024 08:10:00 PM
- Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline • GlobeNewswire Inc. • 05/22/2024 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 09:42:57 PM
- Royalty Pharma to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/13/2024 12:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 01:01:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:17:01 AM
- Royalty Pharma Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
- Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab • GlobeNewswire Inc. • 05/09/2024 10:45:00 AM
- Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024 • GlobeNewswire Inc. • 04/19/2024 12:15:00 PM
- Royalty Pharma Declares Second Quarter 2024 Dividend • GlobeNewswire Inc. • 04/17/2024 12:15:00 PM
- Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/28/2024 09:15:00 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM